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Lactic acidosis secondary to metformin overdose:
a case report
Simon Timbrell1*, Gary Wilbourn1, James Harper2* and Alan Liddle1
Abstract
Introduction: Metformin is a commonly used treatment modality in type 2 diabetes mellitus, with a well
documented side effect of lactic acidosis. In the intensive care setting lactate and pH levels are regularly used as a
useful predictor of poor prognosis. In this article we highlight how high lactate levels are not an accurate predictor
of mortality in deliberate metformin overdose.
Case presentation: We present the case of a 70-year-old Caucasian man who took a deliberate metformin
overdose of unknown quantity. He had a profound lactic acidosis at presentation with a pH of 6.93 and a lactate
level of more than 20mmol/L. These figures would normally correspond with a mortality of more than 80%;
however, with appropriate management this patient’s condition improved.
Conclusion: We provide evidence that the decision to treat severe lactic acidosis in deliberate metformin overdose
should not be based on arterial lactate and pH levels, as would be the case in other overdoses. We also
demonstrate that appropriate treatment with hemodiafiltration and 8.4% sodium bicarbonate, even in patients with
a very high lactate and low pH, can be successful.
Introduction
Metformin is a biguanide typically used as a first line
drug for the treatment of type 2 diabetes mellitus. Its
chief modes of action are reduced absorption of glucose
from the gastrointestinal tract, decreased hepatic gluco-
neogenesis and increased peripheral utilization of glu-
cose [1]. All of these actions lower plasma levels of
glucose.
Commonly reported side effects are predominantly
gastrointestinal and include: nausea, vomiting and ab-
dominal pain. Lactic acidosis is a well-recognized conse-
quence of toxicity and is often associated with
concurrent renal or hepatic insufficiency and in an over-
dose. The mechanism of hyperlactatemia in metformin
toxicity is not fully understood.
The normal range for arterial lactate is 0.5 to
1.6mmol/L. Elevated levels are a common finding within
critical care patients. Levels exceeding 2 to 3mmol/L
have been shown to be an independent marker for mor-
tality in critical care patients with sepsis and in
amitryptyline overdose [2]. Much higher mortality rates
of nearly 70% have been independently associated with
lactate levels of >3.5 [3]. This compelling evidence of ex-
cessive mortality should, however, not be extrapolated to
all causes.
We present a case of deliberate metformin overdose in
which a patient presenting with an arterial lactate of
more than 20mmol/L.
Case presentation
A 70-year-old Caucasian man with type 2 diabetes melli-
tus presented to the emergency department three hours
after a suicide attempt in which an unknown quantity of
metformin was ingested.
At presentation he was vomiting, severely agitated,
confused and complaining of abdominal pain. He had a
heart rate of 100 beats per minute, blood pressure of
150/80mmHg and a respiratory rate of 20. His cardio-
respiratory system was normal; his abdomen was soft
and non-tender.
Arterial blood gas analysis on admission showed a pro-
found lactic acidosis: His temperature was 37.0°C. The
results of his blood analysis are as follows: pH 6.93 (7.38
to 7.42); pCO2 2.1kPa (4.8 to 5.8); pO2 30.4kPa mmol/L
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(12 to 14); actual bicarbonate 3mmol/L (22 to32); base
excess −27.7mmol/L (−2 to 2); and lactate 20.0mmol/L
(0.5 to 2.2). This value is the upper limit of our machine.
Alongside the profound acidaemia, he was anuric with
acute kidney injury and a creatinine of 215μmol/L.
Table 1 shows his blood results at presentation.
He was admitted to the intensive care unit and started
on continuous veno-venous hemodiafiltration
(CVVHDF) with an average blood flow rate of 150mls/
hour (varying between 100 to 180mls/hour) for the 48
hours described in Table 2 and an hourly replacement
flow rate of 1500mls/hour (varying between 1000 to
2000mls/hour) and dialysate replacement with 8.4% so-
dium bicarbonate with an average rate of 1500mls/hour
(varying between 1000 to 2000mls/hour) .
On initiating hemofiltration he developed uncontrolled
atrial fibrillation with cardiovascular compromise requir-
ing amiodarone infusion and vasopressor support.
Despite these initial complications, Table 2 highlights
how quickly the lactic acidosis responded to
hemofiltration.
Despite the clearance of the lactate with CVVHDF his
renal function did not improve. He was offered contin-
ued renal support under the care of the renal physicians
which he refused. He subsequently developed a hospital-
acquired pneumonia, for which he refused active treat-
ment, and died.
Discussion
Lactic acid is produced when there is inadequate tissue
oxygenation for aerobic respiration and lactate is pro-
duced as a by-product of anaerobic respiration catalyzed
by the actions of lactate dehydrogenase on pyruvate, as
shown below:
Pyruviate
þ NADðnicotinamide adenine dinocleotideÞH
þ Hþ
, Lactateþ NADþ
Hyperlactemia is defined as an abnormally high lactate
level between 2 to 5mmol/L whereas lactic acidosis is
defined as a lactate level of more than 5mmol/L and a
pH of less than 7.34.
There are two isomeric forms of lactate: D-lactate, a
byproduct of bacterial metabolism, and L-lactate, pro-
duced in human tissues by anaerobic respiration.
Cohen and Woods [4] divided the causes of lactic
acidosis into 2 categories:
Type A lactic acidosis in which there is clinical
evidence of inadequate tissue perfusion or oxygenation.
This includes:
Anaerobic muscular activity (for example, exercising)
Tissue hypoperfusion (for example, septic shock)
Reduced tissue oxygen delivery or utilization (for
example, severe anaemia), and
Type B lactic acidosis in which there is no clinical evi-
dence of poor tissue perfusion and this is further subdi-
vided into:
B1 - Associated with underlying diseases (for example,
ketoacidosis)
B2 – Associated with several classes of drugs and
toxins (for example, biguanides, salicylates, isoniazid
and alcohol)
B3 - Associated with inborn errors of metabolism (for
example, pyruvate dehydrogenase deficiency).
Metformin-associated lactic acidosis is relatively rare
occurring in 0.03 cases per 1000 patient-years [5]. It
refers to any case of lactic acidosis in a patient taking
Table 1 Blood results at presentation
Clinical Chemistry Parameters Patient’s Values Normal Ranges
Sodium 147 133 to146mmol/L
Potassium 4.1 3.5 to 5.3mmol/L
Urea 8.9 2.5 to 7.8mmol/L
Creatinine 208 64 to 110μmol/L
Bilirubin 11 0 to 21μmol/L
AST 29 5 to 34μ/L
ALT 33 0 to 37μ/L
Alkaline phosphatase 55 3 to 130μ/L
Total protein 80 60 to 80 g/L
C-Reactive Protein 4.5 0 to 8 mg/L
Hemoglobin 15.1 13.5 to 16.9g/dL
Platelets 290 140 to 400× 109/L
White Cell Count 14.40 4.5 to 13.0 × 109/L
Neutrophils 11.40 2 to 7.5 × 109/L
ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Table 2 Response to hemofiltration
Date 0 hours 6 hours 24 hours 48 hours
pH (7.38 to 7.42) 6.93 7.02 7.36 7.37
pCO2 (4.8 to 5.8kPa) 2.1 4.2 5.3 4.8
pO2 (12 to 14kPa) 30.4 15.6 13.3 12.4
Bicarbonate (22 to 32mmol/l) 3 8 23 21
Base Excess (−2 to 2mmol/l) −27.7 −21.7 −2.7 −3.9
Inspired oxygen (%) 60 29 60 40
Creatinine (64 to 110μmol/L) 215 151 167 138
Lactate (0.5 to 2.2mmol/L) >20 >20 13.1 4.0
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metformin where no other lactate-inducing mechanisms,
such as sepsis, are involved. In the majority of cases, the
contribution of metformin is secondary to patient fac-
tors, such as renal insufficiency, liver disease or low car-
diac output states. Although secondary, metformin is
significant. The presence of metformin-associated hyper-
lactatemia in critical care patients has been associated
with a mortality greater than 30% [6].
The patient in this scenario was suffering from
metformin-induced lactic acidosis. This specifically
refers to a situation in which the high lactate level can-
not be explained by any major risk factor other than ex-
cessive metformin intake and is, therefore, a type B2
lactic acidosis. The difference being that metformin ac-
cumulation may coexist with other factors in
metformin-associated lactic acidosis contributing to the
pathogenesis of lactic acidosis, whereas in metformin-
induced lactic acidosis, the lactic acidosis is purely
caused by excessive amounts of metformin.
Deliberate overdose with oral hypoglycemic agents is a
rarer form still of metformin-induced lactic acidosis. A
literature review using the PubMed database only high-
lighted a few case reports and small case series, demon-
strating how rare an occurrence lactic acidosis due to
metformin overdose is. Further evidence of the unusual
nature of the case comes from a five-year review of toxic
exposures reported to US poison control centers. Within
the review only 4072 out of nearly 11 million exposures
involved metformin, corresponding to less than one in
2500 toxic overdoses [7].
Previous case reports of deliberate metformin over-
dose show how individuals with an excessively high lac-
tate level, that would normally be considered
incompatible with life, managed to survive. Gjedde et
al.’s [8] case report demonstrates this, as an individual
deliberately ingested 63 grams of metformin and sur-
vived despite having an initial lactate of 17.7mmol/L. A
case series by Teale et al. [9] described how individuals
with severe metabolic acidosis, the worse being a pH of
6.9 and lactate level of 29mmol/L, survived with appro-
priate management.
The previously published data agreed that the appro-
priate treatment for metformin overdose involves bicar-
bonate hemodialysis [8-11].
Correcting the metabolic acidemia is of paramount
importance in metformin-induced lactic acidosis. So-
dium bicarbonate is often the obvious method; however,
it is not always effective due to lactate being produced at
such a rate that even at high doses, sodium bicarbonate
fails to sustain a normal blood pH. Dichloroacetate and
tri-hydroxymethyl aminomethane are other options that
have been described [11].
Hemodialysis via veno-venous hemodiafiltration with
bicarbonate replacement fluid is deemed more effective,
as the metformin is also cleared via the filter. This how-
ever requires the patient to be hemodynamically stable.
Another way to encourage metformin excretion is to use
furosemide to induce a diuresis which leads to increased
excretion of unchanged metformin in the urine.
In this case the patient received CVVHDF with 8.4%
bicarbonate sodium, which quickly resolved his lactic
acidosis as shown in Table 2.
The association between lactic acidosis and a poor
prognosis has been known for decades. Bakker and Jan-
sen even suggested that lactate was a better indicator of
patient outcome than measuring observations and many
intensivists use it as a guide to patient mortality [12].
Manini et al. demonstrated how serum lactate levels
were a good prognostic marker when used to predict
drug overdose mortality [13].
Given the patient’s initial high lactate level traditional
thoughts and evidence would have predicted a very high
mortality. Indeed, using the Simplified Acute Physiology
Score our patient had a predicted mortality of nearly
80%.
This case highlights how the measurement of arterial
pH and lactate is not such an accurate clinical indicator
in metformin-induced lactic acidosis. This is supported
by Vecchio and Protti’s recent research which suggests
that arterial pH and lactate are not good indicators of
mortality in patients with metformin-associated lactic
acidosis [14]. In their case series involving metformin
overdose the average arterial pH at admission was
6.75 ± 0.13 and lactate was 19 ± 5mmol/L. These patients
had a Simplified Acute Physiology Score II of 88 ± 23
and their predicted mortality was 96%; however, survival
rates were much higher at 50%. This work also com-
pared similarly severe lactic acidosis from non-
metformin associated causes and of the 31 patients,
none survived. This is further supported by the work of
Nyirenda et al. who demonstrated an actual mortality of
10% in metformin overdose against a predicted mortality
of 55% [15].
A proposed mechanism for why metformin-induced
lactic acidosis with such a high lactate level and low pH
may be more reversible is highlighted in further work by
Protti et al. where they suggest biguanides induce lactic
acidosis by impairing hepatocyte mitochondrial function
[16]. Lactate production is, therefore, an epiphenom-
enon due to inhibition of mitochondrial function and
this may explain why rapid removal of the offending
metformin via CVVHDF can effectively treat extremely
high lactate levels [16].
Conclusion
This case report highlights that although there is much
evidence showing that hyperlactatemia is a very poor
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prognostic indicator, this does not necessarily apply to
patients who take a deliberate metformin overdose.
Based on this case and recent research, the decision to
treat (or not to treat) a patient with severe lactic acidosis
with metformin ingestion cannot be based on the arter-
ial lactate and pH, as would be the case in sepsis or
amitriptyline overdose. This scenario highlights that ap-
propriate management with continuous veno-venous
hemodiafiltration and 8.4% sodium bicarbonate can be
used to treat patients successfully who have a perceived
high mortality.
We would, therefore, recommend that all patients with
metformin-induced lactic acidosis must be treated no
matter how high the serum lactate and low the pH, as
renal replacement therapy can efficiently remove metfor-
min and sodium bicarbonate can correct the acidosis.
Consent
Written informed consent for publication from the
patient’s next of kin could not be obtained despite all
reasonable attempts. The patient had no children or liv-
ing family and declined to identify any friends that
should be informed of his admission who could act as a
representative. The case is important to public health
and every effort has been made to protect the identity of
our patient. There is no reason to believe that our
patient’s next of kin would object to publication.
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